At the Annual General Meeting held on September 8, 2021, Downing FOUR VCT plc announced that two new non-executive directors, Dr. Andrew Mackintosh and Steven Clarke, who will join the Board with immediate effect. Dr Andrew Mackintosh has had a distinguished career in industry and investment as a former CEO of FTSE 250 company, Oxford Instruments, before later leading the creation of the Royal Society Enterprise Fund, a pioneering initiative in bringing together scientific expertise and early-stage investment. He was a Board Member of the Intellectual Property Office and a trustee of the Design Council and is currently chairman of Sphere Fluidics Limited, a high-growth biotechnology tools company. Steven Clarke has 30 years’ experience of investing in technology and data businesses including 21 years as a private equity investor with 3i, August Equity and ICG. Steven now supports founders through fundraising, international growth and exit as an investing non-executive director usually alongside a growth equity fund. Steven is also Chair of investment Committee for Bethnal Green Ventures, a Tech for Good impact investor. In addition, Chris Allner, a partner of Downing LLP ("Downing"), the investment manager, and chair of Downing's Investment Committee, will also join the Board as a further non-executive director. The Board believes that Chris’ appointment will be beneficial to the relationship between the Board and the Investment Manager. Chris undertakes a similar role on Downing ONE VCT plc, which has worked well. Chris will not be remunerated as a director of Downing FOUR VCT plc. A final change is that Russell Catley has stepped down as a non-executive director of the Company with immediate effect.